160 related articles for article (PubMed ID: 30456450)
1. Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma.
Ma B; Chen K; Liu P; Li M; Liu J; Sideras K; Sprengers D; Biermann K; Wang W; IJzermans JNM; Cao W; Kwekkeboom J; Peppelenbosch MP; Pan Q
J Mol Med (Berl); 2019 Jan; 97(1):77-88. PubMed ID: 30456450
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol Promoted Interferon-α-Induced Growth Inhibition and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1.
Yang Z; Meng Q; Zhao Y; Han R; Huang S; Li M; Wu X; Cai W; Wang H
J Interferon Cytokine Res; 2018 Jun; 38(6):261-271. PubMed ID: 29762078
[TBL] [Abstract][Full Text] [Related]
3. Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Tang ZY; Qu SF; Chen ZT; Li XW; Zhi XT
Cancer Gene Ther; 2013 Jun; 20(6):366-74. PubMed ID: 23703473
[TBL] [Abstract][Full Text] [Related]
4. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
5. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
[TBL] [Abstract][Full Text] [Related]
6. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1.
Ding H; Liu J; Liu B; Zeng Y; Chen P; Su Y
Biochem Biophys Res Commun; 2018 Jun; 500(4):973-980. PubMed ID: 29715456
[TBL] [Abstract][Full Text] [Related]
8. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
9. Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.
Inamura K; Matsuzaki Y; Uematsu N; Honda A; Tanaka N; Uchida K
Biochim Biophys Acta; 2005 Sep; 1745(3):401-10. PubMed ID: 16054712
[TBL] [Abstract][Full Text] [Related]
10. A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.
Michalska A; Blaszczyk K; Wesoly J; Bluyssen HAR
Front Immunol; 2018; 9():1135. PubMed ID: 29892288
[TBL] [Abstract][Full Text] [Related]
11. Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.
Sung PS; Cheon H; Cho CH; Hong SH; Park DY; Seo HI; Park SH; Yoon SK; Stark GR; Shin EC
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10443-8. PubMed ID: 26216956
[TBL] [Abstract][Full Text] [Related]
12. Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinoma.
Yang Y; Zhou Y; Hou J; Bai C; Li Z; Fan J; Ng IOL; Zhou W; Sun H; Dong Q; Lee JMF; Lo CM; Man K; Yang Y; Li N; Ding G; Yu Y; Cao X
Hepatology; 2017 Jul; 66(1):152-166. PubMed ID: 28295457
[TBL] [Abstract][Full Text] [Related]
13. Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus.
Jilg N; Lin W; Hong J; Schaefer EA; Wolski D; Meixong J; Goto K; Brisac C; Chusri P; Fusco DN; Chevaliez S; Luther J; Kumthip K; Urban TJ; Peng LF; Lauer GM; Chung RT
Hepatology; 2014 Apr; 59(4):1250-61. PubMed ID: 23913866
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1).
Chen Y; Fu H; Zhang Y; Chen P
Med Sci Monit; 2019 Dec; 25():9471-9482. PubMed ID: 31827061
[TBL] [Abstract][Full Text] [Related]
15. Hyper-activated IRF-1 and STAT1 contribute to enhanced interferon stimulated gene (ISG) expression by interferon alpha and gamma co-treatment in human hepatoma cells.
Zhang XN; Liu JX; Hu YW; Chen H; Yuan ZH
Biochim Biophys Acta; 2006; 1759(8-9):417-25. PubMed ID: 16987558
[TBL] [Abstract][Full Text] [Related]
16. Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells.
Ichikawa T; Nakao K; Nakata K; Yamashita M; Hamasaki K; Shigeno M; Abiru S; Ishikawa H; Ishii N; Eguchi K
Biochem Biophys Res Commun; 2002 Jun; 294(2):414-22. PubMed ID: 12051728
[TBL] [Abstract][Full Text] [Related]
17. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
18. Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells.
Zhao LJ; Hua X; He SF; Ren H; Qi ZT
Virol J; 2011 Apr; 8():157. PubMed ID: 21466707
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells.
Li W; Huang X; Tong H; Wang Y; Zhang T; Wang W; Dai L; Li T; Lin S; Wu H
PLoS One; 2012; 7(10):e47040. PubMed ID: 23056571
[TBL] [Abstract][Full Text] [Related]
20. Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
He Y; Huang J; Wang P; Shen X; Li S; Yang L; Liu W; Suksamrarn A; Zhang G; Wang F
Oncotarget; 2016 Jan; 7(4):4664-79. PubMed ID: 26683360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
